CLOSED
NIFTY 5022,453.30+0.98%SENSEX74,235.62+1.24%BANK NIFTY48,892.15+1.45%NIFTY IT35,124.80-0.52%NIFTY MIDCAP52,487.25+0.87%NIFTY 5022,453.30+0.98%SENSEX74,235.62+1.24%BANK NIFTY48,892.15+1.45%NIFTY IT35,124.80-0.52%NIFTY MIDCAP52,487.25+0.87%
Home/Business/Warburg Pincus to Acquire Koye Pharma in…

Warburg Pincus to Acquire Koye Pharma in India

Business
By ThePip Desk•
Add as a preferred source on Google
A professional image showing various medicine blisters and bottles on a wooden surface, with a futuristic India map and financial graphs in the background.

Warburg Pincus Eyes Koye Pharma in Healthcare Expansion

Key Highlights

Warburg Pincus nears acquisition of Koye Pharma, a Mumbai-based drugmaker specializing in women’s health, respiratory care, and anti-diabetes. Third investment in India.

Global private equity fund Warburg Pincus is close to finalizing an agreement to purchase Koye Pharma. The Mumbai-based drugmaker specializes in women’s health products, respiratory care solutions, and anti-diabetes medications.

The acquisition is valued at approximately ₹300 crore and represents Warburg Pincus’s third investment in the expanding Indian pharmaceutical sector. Koye Pharma has demonstrated substantial growth in recent years, with sales reaching around ₹160 crore.

Gallery image 42
IndiaKoye PharmaMedicinesWarburg Pincus